BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ox.ac.uk//NONSGML oxford.event//EN
X-WR-TIMEZONE:Europe/London
BEGIN:VTIMEZONE
TZID:Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:BST
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:GMT
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SUMMARY:Extrachromosomal DNA (ecDNA): Cancer's Dynamic Circular Genome
DTSTART;TZID=Europe/London:20260603T120000
DTEND;TZID=Europe/London:20260603T130000
DTSTAMP:20260523T195003Z
UID:447af1e1-5e53-f111-bec7-6045bd12f634
CREATED:20260519T084403Z
DESCRIPTION:Paul Mischel\, M.D. is the Fortinet Founders Professor\, Vice 
 Chair for Research for the Department of Pathology\, and Deputy Director o
 f Translational Science and an Institute Scholar at Sarafan ChEM-H\, Stanf
 ord University. Mischel\, who leads the eDyNAmiC Cancer Grand Challenges T
 eam\, has made important contributions to the scientific understanding of 
 extrachromosomal DNA (ecDNA) in cancer development\, progression\, and the
 rapeutic resistance and the development of innovative techniques to study 
 ecDNA. His research\, published in Nature\, Science\, and Cell\, and highl
 ighted in a recent profile in Science Magazine (https://www.science.org/co
 ntent/article/weird-rings-dna-fuel-cancers-scientist-leads-effort-target-t
 hem)\, has catalyzed a paradigm shift in the fundamental understanding of 
 cancer biology\, and his leadership has opened a new field that has led to
  the development of new drugs being tested in the clinic. Mischel is a mem
 ber of the National Academy of Medicine\, a Fellow of the AACR Academy\, a
 nd Past-President of the American Society for Clinical Investigation. He i
 s an academic co-founder of Boundless Bio and Alterris Oncology.\n\nPaul M
 ischel M.D.\, FAACR\nFortinet Founders Professor\nProfessor\, By Courtesy\
 , Department of Neurosurgery\nVice Chair for Research\, Department of Path
 ology\nInstitute Scholar and Deputy Director\, Translational Science\, Sar
 afan ChEM-H\nStanford University
LAST-MODIFIED:20260519T085608Z
LOCATION:MRC Weatherall Institute of Molecular Medicine - WIMM Seminar roo
 m\, WIMM Seminar room MRC Weatherall Institute of Molecular Medicine Headi
 ngton Oxford Oxfordshire OX3 9DS United Kingdom
SPEAKER:Professor Paul Salomon Mischel (Stanford University)
END:VEVENT
END:VCALENDAR